In this conversation, Handol shares how his team is rethinking drug discovery using generative AI, tackling one of the most complex and high-stakes challenges in science.
From a 25-year career in tech to becoming what he calls an “immigrant to biotech,” his journey is anything but typical. What stood out the most is how brutally honest he is about the realities of both AI and biotech.
Drug discovery, as he explains, is a 10–12 year process with massive costs and a very low success rate. “It’s the most expensive lottery ticket in the world.”
That’s exactly the problem Variational AI is trying to solve.